The stock of Redhill Biopharma Ltd. ADR (NASDAQ:RDHL) last traded at $1.66, down -17.00% from the previous session.
Data from the available sources indicates that Redhill Biopharma Ltd. ADR (NASDAQ:RDHL) is covered by 1 analysts. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $40.00 and a low of $40.00, we find $40.00. Given the previous closing price of $2.00, this indicates a potential upside of 1900.0 percent. RDHL stock price is now 195.05% away from the 50-day moving average and -28.65% away from the 200-day moving average. The market capitalization of the company currently stands at $18.38M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
In total, 0 analysts have assigned it a hold rating, and 1 have given it a buy rating. Brokers who have rated the stock have averaged $40.00 as their price target over the next twelve months.
With the price target of $22, Cantor Fitzgerald recently initiated with Overweight rating for Redhill Biopharma Ltd. ADR (NASDAQ: RDHL).
A total of 0.50% of the company’s stock is owned by insiders.
With an opening price of $1.8900 on Friday morning, Redhill Biopharma Ltd. ADR (NASDAQ: RDHL) set off the trading day. During the past 12 months, Redhill Biopharma Ltd. ADR has had a low of $0.26 and a high of $15.20. As of last week, the company has a debt-to-equity ratio of 0.66, a current ratio of 0.96, and a quick ratio of 0.78. The fifty day moving average price for RDHL is $0.5807 and a two-hundred day moving average price translates $2.2921 for the stock.
The latest earnings results from Redhill Biopharma Ltd. ADR (NASDAQ: RDHL) was released for Jun, 2023. According to the Drug Manufacturers – Specialty & Generic Company, earnings per share came in at -$0.2, missing analysts’ expectations of -$0.03 by -0.17. This compares to -$8.24 EPS in the same period last year. For the current quarter, analysts expect RDHL to generate $17.55M in revenue.
